- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
补阳还五汤对冠心病心绞痛患者血凝及预后影响
补阳还五汤对冠心病心绞痛患者血凝及预后影响[摘要] 目的 探讨补阳还五汤对冠心病心绞痛患者凝血功能及预后的影响。 方法 选择我院78例冠心病心绞痛患者,将其随机分为对照组及治疗组,每组各39例,对照组进行常规扩冠、抗凝等治疗,观察组在常规治疗基础上加用补阳还五汤治疗,疗程为4周,比较两组患者临床疗效及治疗前后凝血功能变化。并对患者进行随访,比较两组患者预后情况。 结果 治疗组临床总有效率为97.4%,对照组临床总有效率为87.2%,治疗组临床总有效率高于对照组(P 0.05)。治疗前两组患者部分活化凝血酶源时间(prothrombin time,PT),活化部分凝血活酶时间(activated partial thromboplastin time,APTT),凝血酶时间(thrombin time,TT),纤维蛋白原(fibrinogen,Fb)比较无显著差异,治疗后治疗组PT、APTT、TT时间长于对照组(P 0.05)。治疗后随访1年,治疗组再住院及急性心血管意外发生率均低于对照组(均P 0.05)。 结论 补阳还五汤能够改善冠心病心绞痛患者血凝异常状态,减少心血管意外的发生,改善疗效及预后。
[关键词] 补阳还五汤;冠心病;心绞痛;血凝;心血管意外
[中图分类号] R285.5 [文献标识码] A [文章编号] 1673-7210(2012)07(b)-0087-03
Effect on Buyang Huanwu Decoction to cruor fuction and prognosison patients with angina pectoris
LI Xiuying
Department of Emergency, Traditional Chinese Medical Hospital of Neijiang City, Sichuan Province, Neijiang 641000, China
[Abstract] Objective To investigate the effect of Buyang Huanwu Decoction for cruor fuction and prognosis on patients with coronary heart disease angina pectoris. Methods 78 cases of patients with coronary heart disease angina pectoris were selected and randomized into control group and theatment group, each group had 39 cases. All patients taken treatment with expanding coronary artery and anticoagulant therapy and so on, patients in theatment group taken Buyang Huanwu Decoction in additional, course of treatment were four weeks, curative effect change of cruor fuction were contrasted between two groups. All patients were followed up, prognosis were contrasted between two groups. Results The total clinical effective rate was 97.4% in treatment group and was 87.2% in control group, The total clinical effective rate was higher in reatment group than that of control group, prothrombin time (PT), level of activated partial thromboplastin time (APTT), thrombin time (TT) and fibrinogen (Fb) before treatment was identical between two groups, after treatment,level of PT, APTT and TT were longer in treatment group than that of control group, all pa
您可能关注的文档
最近下载
- 高校企业产学研合作协议范本.doc VIP
- 2024-2025学年河南省百师联盟高二年级上册10月联考数学试题(含答案).pdf VIP
- 企业与高校产学研合作协议(产学研合作协议范本).docx VIP
- 蟋蟀的住宅-课堂演示课件.ppt VIP
- 《环境化学导论》课件.ppt VIP
- 商务统计学第八章习题chap08-TIF-BSAFC5.pdf
- A级景区安全风险辨识评估标准清单.docx VIP
- 南方GPS静态测量及数据处理(实例).pdf VIP
- 新22J07 室外工程-标准图集.docx VIP
- DB32/T 3545.7-2024血液净化治疗技术管理 第7部分:血液透析用水卫生检测规范.pdf VIP
文档评论(0)